Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.05% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 9.2% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
indie Semiconductor
INDI
$995M
| $1.85M | ﹤0.01% |
317,172
-12,540
| -4% | -$92.5K |
|
2902
El Pollo Loco
LOCO
$473M
| $1.85M | ﹤0.01% |
185,250
-4,651
| -2% | -$48.5K |
|
2903
NWPX Infrastructure Inc
NWPX
$1.12B
| $1.84M | ﹤0.01% |
54,537
+375
| +0.7% | +$12.7K |
|
2904
Stagwell
STGW
$2.23B
| $1.83M | ﹤0.01% |
294,303
-15,593
| -5% | -$112K |
|
2905
Brookfield Infrastructure Partners
BIP
$18.3B
| $1.82M | ﹤0.01% |
58,885
-1,067
| -2% | -$37.3K |
|
2906
Aehr Test Systems
AEHR
$4.37B
| $1.82M | ﹤0.01% |
90,432
+18,761
| +26% | +$401K |
|
2907
Civista Bancshares
CIVB
$593M
| $1.81M | ﹤0.01% |
82,419
-2,334
| -3% | -$52.6K |
|
2908
Orrstown Financial Services
ORRF
$852M
| $1.8M | ﹤0.01% |
77,588
-2,935
| -4% | -$75K |
|
2909
Genie Energy
GNE
$383M
| $1.8M | ﹤0.01% |
173,748
+101,559
| +141% | +$989K |
|
2910
Mitek Systems
MITK
$877M
| $1.8M | ﹤0.01% |
185,305
+14,566
| +9% | +$153K |
|
2911
Protagonist Therapeutics
PTGX
$10B
| $1.79M | ﹤0.01% |
164,325
+6,266
| +4% | +$52.9K |
|
2912
MVB Financial
MVBF
$398M
| $1.79M | ﹤0.01% |
81,394
+26,448
| +48% | +$646K |
|
|
ESPR
2913
DELISTED
Esperion Therapeutics
ESPR
| $1.78M | ﹤0.01% |
286,286
+13,880
| +5% | +$99.3K |
|
|
INST
2914
DELISTED
Instructure Holdings, Inc.
INST
| $1.78M | ﹤0.01% |
76,049
+24,303
| +47% | +$567K |
|
2915
Lifestance Health
LFST
$4.75B
| $1.78M | ﹤0.01% |
360,495
-6,362
| -2% | -$39.3K |
|
2916
MaxCyte
MXCT
$141M
| $1.78M | ﹤0.01% |
338,282
+4,509
| +1% | +$27.6K |
|
2917
iShares Treasury Floating Rate Bond ETF
TFLO
$6.72B
| $1.78M | ﹤0.01% |
35,236
+26,648
| +310% | +$1.34M |
|
|
NVEI
2918
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $1.77M | ﹤0.01% |
69,466
+362
| +0.5% | +$10.3K |
|
2919
Nurix Therapeutics
NRIX
$2.81B
| $1.76M | ﹤0.01% |
160,544
+1,784
| +1% | +$21.5K |
|
|
ZIMV
2920
DELISTED
ZimVie
ZIMV
| $1.76M | ﹤0.01% |
188,114
+3,197
| +2% | +$27.9K |
|
2921
iQIYI
IQ
$1.3B
| $1.76M | ﹤0.01% |
331,197
-265,242
| -44% | -$773K |
|
2922
Cimpress
CMPR
$2.3B
| $1.75M | ﹤0.01% |
63,519
-2,383
| -4% | -$61.8K |
|
2923
Vanguard Russell 2000 ETF
VTWO
$17.6B
| $1.75M | ﹤0.01% |
24,879
-4,421
| -15% | -$318K |
|
2924
Aurinia Pharmaceuticals
AUPH
$2.06B
| $1.74M | ﹤0.01% |
403,834
-3,517
| -0.9% | -$20.4K |
|
2925
First Trust Europe AlphaDEX Fund
FEP
$536M
| $1.74M | ﹤0.01% |
54,203
+10,905
| +25% | +$331K |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.